BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24527863)

  • 21. Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.
    Bates JE; Choi G; Milano MT
    J Neurooncol; 2016 Sep; 129(2):251-8. PubMed ID: 27306443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology and management of ependymomas.
    Wu J; Armstrong TS; Gilbert MR
    Neuro Oncol; 2016 Jul; 18(7):902-13. PubMed ID: 27022130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myxopapillary ependymomas in children: imaging, treatment and outcomes.
    Bandopadhayay P; Silvera VM; Ciarlini PDSC; Malkin H; Bi WL; Bergthold G; Faisal AM; Ullrich NJ; Marcus K; Scott RM; Beroukhim R; Manley PE; Chi SN; Ligon KL; Goumnerova LC; Kieran MW
    J Neurooncol; 2016 Jan; 126(1):165-174. PubMed ID: 26468139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal drop metastasis in myxopapillary ependymoma: a case report and a review of treatment options.
    Bates JE; Peterson CR; Yeaney GA; Walter KA; Lundquist T; Rosenzweig D; Milano MT
    Rare Tumors; 2014 May; 6(2):5404. PubMed ID: 25002955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
    Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
    Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.
    Oh MC; Ivan ME; Sun MZ; Kaur G; Safaee M; Kim JM; Sayegh ET; Aranda D; Parsa AT
    Neuro Oncol; 2013 Feb; 15(2):208-15. PubMed ID: 23229996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
    Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
    J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
    Lin Y; Jea A; Melkonian SC; Lam S
    J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas.
    Chao ST; Kobayashi T; Benzel E; Reddy CA; Stevens GH; Prayson RA; Kalfas I; Schlenk R; Krishnaney A; Steinmetz MP; Bingaman W; Hahn J; Suh JH
    J Neurosurg Spine; 2011 Jan; 14(1):59-64. PubMed ID: 21142463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life.
    Kukreja S; Ambekar S; Sin AH; Nanda A
    J Neurosurg Pediatr; 2014 Apr; 13(4):400-7. PubMed ID: 24527863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review.
    Feldman WB; Clark AJ; Safaee M; Ames CP; Parsa AT
    J Neurosurg Spine; 2013 Oct; 19(4):471-6. PubMed ID: 23971762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
    Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
    J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome predictors in the management of spinal myxopapillary ependymoma: an integrative survival analysis.
    Kukreja S; Ambekar S; Sharma M; Sin AH; Nanda A
    World Neurosurg; 2015 May; 83(5):852-9. PubMed ID: 25108296
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.